New Epigenetic Signature Discovered in Zebrafish | Genetics And Genomics

Researchers are increasingly understanding the significant role of genetics in the development of ALS. Thanks to funding from the ALS Canada Research Program, Dr. Gary Armstrong from the Montreal Neurological Institute at McGill University is studying CRISPR/CAS9, a state-of-the-art technology that enables scientists to precisely manipulate and edit genes in living organisms and apply this technique to ALS. While it’s too soon for this technology to be used in humans, he is using CRISPR/CAS9 to